首页> 美国卫生研究院文献>AAPS PharmSciTech >Development of Bilayer Floating Tablet of Amoxicillin and Aloe vera Gel Powder for Treatment of Gastric Ulcers
【2h】

Development of Bilayer Floating Tablet of Amoxicillin and Aloe vera Gel Powder for Treatment of Gastric Ulcers

机译:阿莫西林芦荟凝胶粉双层漂浮片治疗胃溃疡的研究进展。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Usual treatment for Helicobacter pylori-induced peptic ulcer includes a ‘triple therapy’ consisting of two antibiotics (amoxicillin and clarithromycin) and a proton pump inhibitor (omeprazole). The objective of this project work was defined with a view to retain the drug in stomach for better antiulcer activity and substituting one of the synthetic drugs in this therapy with a herbal alternative. Hence, aim of the present work was to design and develop a bilayer floating tablet of amoxicillin and Aloe vera gel powder for the treatment of peptic ulcer. A. vera gel powder is used for its cytoprotective action. Bilayer floating tablets were prepared by applying direct compression technique. The proportion of sodium bicarbonate and citric acid was adjusted to get the least possible lag time with good matrix integrity and total floating time. Polymer concentration was adjusted to get the maximum release in 8 h. The formulation was developed using hydroxypropyl methyl cellulose (HPMC) K4M and HPMC K100M in a ratio of 85:15 along with 1:4 ratio of effervescent agents was found to give floating lag time of less than 1 min with total floating time of more than 8 h and 97.0% drug release in 8 h. In vivo study in rats meets the requirement of antiulcer activity for bilayer tablet in comparison to single amoxicillin as standard.
机译:幽门螺杆菌诱发的消化性溃疡的常规治疗包括“三联疗法”,该三联疗法由两种抗生素(阿莫西林和克拉霉素)和质子泵抑制剂(奥美拉唑)组成。确定该项目工作的目的是为了将药物保留在胃中以提高抗溃疡活性,并用草药替代该疗法中的一种合成药物。因此,本发明的目的是设计和开发一种用于治疗消化性溃疡的阿莫西林和芦荟凝胶粉的双层漂浮片剂。维拉凝胶粉末用于其细胞保护作用。通过直接压片技术制备双层浮片。调整碳酸氢钠和柠檬酸的比例,以使延迟时间最短,并具有良好的基质完整性和总漂浮时间。调整聚合物浓度以在8小时内获得最大释放量。使用羟丙基甲基纤维素(HPMC)K4M和HPMC K100M以85:15的比例以及1:4的泡腾剂比例开发配方,发现浮滞时间小于1分钟,总浮起时间大于1分钟8小时和8小时内97.0%的药物释放。与标准阿莫西林相比,大鼠体内研究符合双层片剂抗溃疡活性的要求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号